ALPHA-SYNUKLEIN ERKENNENDE HUMANISIERTE ANTIKÖRPER

European patent · EP3378535 · In force

Register entry

Publication number
EP3378535
Application number
EP18155441
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 26, 2012
Published
Sep 26, 2018
Granted
Jan 4, 2023
Protection ends at the latest
Oct 25, 2032
Next annual fee due
Oct 31, 2027
IPC classes
A61P 25/16 (2006.01)
A61K 39/00 (2006.01)
C07K 16/18 (2006.01)
Priority
US 201161553131 P 28.10.2011
US 201261711208 P 08.10.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. Jan 26, 2024

    Change

    Published in Swissreg on 26.01.2024

  5. Nov 15, 2023

    Change

    Published in Swissreg on 15.11.2023

  6. Jan 12, 2023

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 12.01.2023

  7. Jan 4, 2023

    Granted

    Published in Swissreg on 04.01.2023

Parties

Holder

Prothena Biosciences Limited

77 Sir John Rogerson's Quay, Block C Grand Canal Docklands, Dublin 2, D02 VK60, IE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

SALDANHA, Jose

Enfield, Middlesex EN1 3BD, GB

NIJJAR, Tarlochan

Orinda, CA 94563, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.